Quarterly report · Q1
2269.TEDINET S100RKR4
Period2023-04-01 → 2023-06-30
Filed2023-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥262.7bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥1.06T | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥247.1bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥19.5bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥18.0bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥19.2bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥74.2bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥18.4bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥22.6bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥23.2bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.6bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥69.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥16.0bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥12.5bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥16.2bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥1.17T | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥1.14T | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.14T | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥409.7bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥384.9bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥762.1bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥751.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥725.4bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥84.1bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥63.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥81.0bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥60.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥84.9bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.9bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.4bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥85.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.7bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥5.7bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥36.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥9.0bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥22.5bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥54.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥22.3bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥41.59 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥247.39 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.87 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 61.6% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥151m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥151m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥310m |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥218.7bn |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥218.6bn |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥147m |
| jpcrp040300-q1r_E21902-000Foodreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥15.2bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥44.2bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥44.2bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥3m |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-06-30 | ¥262.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-06-30 | ¥262.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥151m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-06-30 | ¥19.8bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥140m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥140m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥278m |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥204.4bn |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥204.3bn |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥131m |
| jpcrp040300-q1r_E21902-000Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥14.5bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥42.9bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥42.9bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥9m |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥247.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥247.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥140m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥18.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 498
| Item | Context | Value | Unit |
|---|---|---|---|
| Income before income taxes | CurrentYTDDuration | 22630000000 | JPY |
| Income taxes | Prior1YTDDuration | 7002000000 | JPY |
| Income taxes | CurrentYTDDuration | 10140000000 | JPY |
| Profit loss | Prior1YTDDuration | 16155000000 | JPY |
| Profit loss | CurrentYTDDuration | 12489000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 139000000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 896000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 16015000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 11593000000 | JPY |
| Profit loss | Prior1YTDDuration | 16155000000 | JPY |
| Profit loss | CurrentYTDDuration | 12489000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -2553000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 6156000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | Prior1YTDDuration | 24000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | CurrentYTDDuration | 324000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 7713000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 4822000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | 643000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | 42000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | 4078000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | 492000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 9906000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 11839000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 26062000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 24329000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 25848000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 23362000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 214000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 966000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 23158000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 22630000000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 12948000000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 13486000000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 3000000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 3000000 | JPY |
| Loss on retirement of property plant and equipment ope cf | Prior1YTDDuration | 552000000 | JPY |
| Loss on retirement of property plant and equipment ope cf | CurrentYTDDuration | 876000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | -22000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | 11000000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | -4823000000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -4548000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | 1062000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | 134000000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -784000000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -808000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 122000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 94000000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YTDDuration | 59000000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYTDDuration | 1040000000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | Prior1YTDDuration | -4418000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |